We have located links that may give you full text access.
Carmustine-Associated Pneumonitis Presenting as a Unilateral Pleural Effusion.
Chest 2014 October 2
SESSION TITLE: Pleural Case Report PostersSESSION TYPE: Affiliate Case Report PosterPRESENTED ON: Tuesday, October 28, 2014 at 01:30 PM - 02:30 PMINTRODUCTION: We report, to our knowledge, the first case of Carmustine-associated pneumonitis presenting with a unilateral pleural effusion.CASE PRESENTATION: A 62-year old male presented with a right pleural effusion as well as mediastinal and hilar lymphadenopathy. Mantle cell lymphoma was diagnosed by transbronchial lymph node biopsy and pleural fluid cytology. He underwent 6 cycles of chemotherapy and achieved complete remission on PET CT. He subsequently underwent autologous bone marrow transplant with a conditioning regimen of Carmustine 550mg/m2 (1122mg), Etoposide 60mg/kg and Cyclophosphamide 100mg/kg. Five weeks later, he reported worsening fatigue and dyspnea on exertion. A CT thorax revealed a large right-sided pleural effusion with associated patchy ground glass opacities affecting multiple lobes (Figure 1). Pleural fluid (Table 1) analysis revealed a lymphocytic predominant, exudative process. Microbiological and cytological assays were all negative. An ultrasensitive assay (ClonoSIGHT, Sequenta, CA) was negative for recurrent lymphoma. Cardiac function was within normal limits. Following a lack of response to empiric antibiotics, the patient was started on prednisone 1mg/kg, which resulted in a rapid improvement of symptoms. A repeat chest radiograph demonstrated near resolution of the pleural effusion and he had corresponding improvements in pulmonary function tests.DISCUSSION: Carmustine induced pulmonary toxicity has been previously reported to cause bilateral pleural and pericardial effusions [1]. In our case the occurrence of symptoms after conditioning with high dose Carmustine (>1000mg), diffuse ground glass infiltrates on CT and remarkable response to corticosteroids favors the diagnosis of Delayed Pulmonary Toxicity Syndrome (DPTS) over the Idiopathic Pneumonia Syndrome (IPS) [2]. It was necessary to exclude infection and the relapse of lymphoma in this patient with an exudative and predominantly lymphocytic pleural effusion. This patient may have been predisposed to develop this unique presentation of DPTS, as he previously presented with a lymphoma positive pleural effusion affecting the same hemithorax, which may have resulted in a partial defect of the lymphatic drainage of his right hemithoraxCONCLUSIONS: Carmustine-associated DPTS can present as a unilateral pleural effusion. Prompt initiation of steroids upon establishing this diagnosis should lead to the rapid improvement of symptoms.Reference #1: Krishnan, G.S. et al., Ann Transplant, 2008Reference #2: Panoskaltsis-Mortari, A. et al, AJRCCM 2011DISCLOSURE: The following authors have nothing to disclose: Chunrong Lin, Kapilkumar Patel, Joe HsuNo Product/Research Disclosure Information.
Full text links
Related Resources
Trending Papers
Executive Summary: State-of-the-Art Review: Unintended Consequences: Risk of Opportunistic Infections Associated with Long-term Glucocorticoid Therapies in Adults.Clinical Infectious Diseases 2024 April 11
Autoimmune Hemolytic Anemias: Classifications, Pathophysiology, Diagnoses and Management.International Journal of Molecular Sciences 2024 April 13
Clinical practice guidelines on the management of status epilepticus in adults: A systematic review.Epilepsia 2024 April 13
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app